“The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?” Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post “Impact” blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs “deals with treatment, the target on ‘essential medicines and basic technologies for treatment.'” She continues, “Treatment and prevention are heavily interrelated. The success of one is directly related to the other.” She adds, “A person in the developing world will not buy in to the importance of prevention if there is no treatment option available should that person get the disease.”
Access to Health Services
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26, youth activist Cecilia Garcia Ruiz writes, “For six years we’ve worked to shine a spotlight on these key issues, but some people still disregard the importance of providing universal access to quality contraceptive services and information to prevent unplanned pregnancies, especially among young people.” She discusses barriers to accessing contraceptive methods and information, and continues, “These problems not only undermine our well-being, but also hinder our possibilities to develop our full potential. Therefore, young people’s access to contraceptive information and services becomes a human rights issue” (9/13).
“International relief officials reported an increasingly grim aid crisis stemming from the Syria conflict on Tuesday, with two million people there not getting desperately needed help, and a sudden acceleration of refugees overwhelming the ability of neighboring countries to absorb them,” the New York Times reports. “In the province of Homs, so many doctors have fled that only three surgeons remained to serve a population of two million, the officials said,” according to the newspaper. “The World Health Organization said that a United Nations mission to Homs last week had found that more than half a million people needed aid, including health care, food and water,” it writes, adding, “The mission found that the biggest hospital in Homs had been destroyed, and that only six of the 12 public hospitals and eight of the 32 private hospitals were still functional.” The newspaper notes, “At the United Nations, the head of UNICEF and the European Union’s top relief official said that only about one-third of the three million people in Syria who needed help were getting any, and that combatants on both sides would be held responsible for respecting international law protecting civilians during war” (Cumming-Bruce/MacFarquhar, 9/11).
Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center’s “Global Health Policy” blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria “might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back,” but “with the current poor status of basic information on beneficiaries and costs, it’s difficult to judge whether these cuts are good or bad.” They outline the history of AIDS funding in Ethiopia, posit what future funding might encompass, and say additional information is needed from PEPFAR, the Global Fund, and the Ethiopian government in order to know the true impacts of reduced funding (9/11).
Pending Cases Against India's Patent Laws Threaten Public Health, Misinterpret International IP Agreements, Report Says
“Pending cases against India’s patent laws threaten public health and misinterpret international intellectual property (IP) agreements,” researchers from Queen Mary, University of London argue in a special report published online in the Lancet on Monday, PharmaTimes reports (Taylor, 9/11). “The report highlights legal challenges by two pharmaceutical companies, Bayer and Novartis, to key provisions of India’s Patents Act,” a university press release notes, adding, “Bayer’s appeal was heard last week, and the Indian Supreme Court is due to hear Novartis’ appeal on 11 September.”
The Australian Agency for International Development (AusAID) “is planning to boost support for medical research, technology and innovations,” as well as “encourage collaboration and capacity building aimed at poverty-related and neglected tropical diseases,” SciDev.Net reports. The agency’s draft Medical Research Strategy for the Pacific “outlines how AusAID will support research both at the ‘preventative end and at the curative end’ to create new medical products such as diagnostics, drugs or vaccines, and to improve the clinical treatment of people in poor communities” and “says there are hardly any financial incentives for commercial investment in diseases affecting the poor, who bear the biggest burden of disease,” according to the news service. “The strategy fits within the Australian government’s overall policy of making aid more effective,” SciDev.Net states, noting an AusAID spokesperson based in Canberra said, “Practical research will help inform where and how the resources of Australia and its partners can be most effectively and efficiently deployed” (Jackson, 9/10).
“Right now, in Leesburg, Va., the office of the U.S. Trade Representative is negotiating a so-called ‘trade agreement’ — the ‘Trans-Pacific Partnership Agreement’ — that could put the lives of millions of innocent civilians at risk” by potentially limiting access to life-saving medications, including antiretroviral drugs, Robert Naiman, policy director at Just Foreign Policy, writes in the Huffington Post Blog. “The process is secret: USTR refuses to publish a draft negotiating text, so any American who isn’t cleared by USTR to see the text can’t say for sure exactly what USTR is doing right now,” he writes, adding, “But because there was a previous leak of the chapter of the draft negotiating text that dealt with intellectual property claims, people who have followed these issues closely have some idea of what USTR has been doing on our dime.”
In a post on IntraHealth’s “Global Health Blog,” Rebecca Kohler, senior vice president of corporate strategy and development at IntraHealth, writes about an event held last week on the sidelines of the Democratic National Convention (DNC) that “focused on the vital role of women’s health in foreign policy.” She writes, “I was encouraged by the level of commitment to a robust global family planning program on the part of our U.S. Congresswomen and the convention delegates. But I also was inspired by the effective role the U.N. Foundation plays in informing, mobilizing, and activating Americans across the country about critical health and development challenges.” Noting that the Kaiser Family Foundation’s 2012 Survey of Americans on the U.S. Role in Global Health “shows that the more informed the public is about global health issues, and how U.S. foreign assistance is saving lives, the more likely they are to support increased funding for health beyond this country’s borders,” Kohler concludes, “Informed and activated Americans are a driving force for change, and the DNC advocacy event was a great reminder that despite the hyper focus on domestic issues during this campaign, people can and do care about global issues” (9/10).
The Economist reports on a demonstration by about 300 people living with HIV and activists outside the headquarters of China’s Henan provincial government in Zhengzhou on August 27. “Many of the … participants were infected in government-backed blood-selling schemes in the 1990s,” the magazine writes, adding, “Tens of thousands contracted HIV this way. The government has never admitted responsibility.” According to the Economist, “As the Communist Party prepares for an imminent leadership change it is more than usually anxious to keep the AIDS scandal quiet.”
“An increasing number of developing countries are introducing universal health care coverage — and creating new models to do it — according to research … by the Results for Development Institute and others, published in the Lancet as part of its universal health care coverage series,” IRIN reports. “Lessons learned from countries like Ghana, India, and Rwanda are already shaping the way countries like South Africa are beginning to pilot their own bids for universal coverage,” the news service writes. “The research, which surveyed nine developing countries in Africa and Asia (which are now part of a joint learning network on the issue) found that the new models vary considerably but have several common characteristics, including increased revenue and health budgets, larger risk pools and use of the private sector,” IRIN adds, and details some of the findings (9/11).